• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人血浆中分离纤溶酶原激活剂,并与人子宫组织和尿液中的激活剂进行比较。

Separation of plasminogen activators from human plasma and a comparison with activators from human uterine tissue and urine.

作者信息

Kok P

出版信息

Thromb Haemost. 1979 Jun 30;41(4):734-44.

PMID:483246
Abstract

Normal human plasma contains acid-stable as well as labile plasminogen activators. The activity of activators in plasma euglobulins was inhibited by EACA in an uniform pattern, similar to that obtained with the major activators in human uterine tissue or with the purified porcine tissue activator, but different from the patterns obtained with plasmin or with urokinase. Gel filtration at high ionic strength separated activators corresponding to particle sizes of 60,000 dalton and about 10,000 dalton, corresponding to two activators similarly obtained from human tissue. The 60,000 dalton activator was precipitated in the euglobulin fraction. Its concentration increased in plasma after exercise. The 10,000 dalton activator was found mainly in the supernatant. Gel filtration in 0.15 M solutions yielded activators in fractions of molecular sizes of 100-140,000 dalton and 200,000 dalton or larger. The activity of normal and exercise euglobulins was inhibited by antiserum to a plasminogen activator prepared from porcine tissue, but it was not inhibited by antiserum to urokinase. Plasminogen activators in human plasma euglobulins resembled immunochemically the activators in human uterine tissue.

摘要

正常人血浆中含有酸稳定和不稳定的纤溶酶原激活剂。血浆优球蛋白中激活剂的活性被6 -氨基己酸以一种均匀的模式抑制,这与在人子宫组织中的主要激活剂或纯化的猪组织激活剂所获得的模式相似,但与纤溶酶或尿激酶所获得的模式不同。在高离子强度下进行凝胶过滤分离出对应于60,000道尔顿和大约10,000道尔顿颗粒大小的激活剂,这与从人体组织中类似获得的两种激活剂相对应。60,000道尔顿的激活剂沉淀在优球蛋白部分。运动后其在血浆中的浓度升高。10,000道尔顿的激活剂主要存在于上清液中。在0.15 M溶液中进行凝胶过滤,在分子大小为100 - 140,000道尔顿和200,000道尔顿或更大的部分中产生激活剂。正常和运动优球蛋白的活性被针对从猪组织制备的纤溶酶原激活剂的抗血清抑制,但不被抗尿激酶抗血清抑制。人血浆优球蛋白中的纤溶酶原激活剂在免疫化学上类似于人子宫组织中的激活剂。

相似文献

1
Separation of plasminogen activators from human plasma and a comparison with activators from human uterine tissue and urine.从人血浆中分离纤溶酶原激活剂,并与人子宫组织和尿液中的激活剂进行比较。
Thromb Haemost. 1979 Jun 30;41(4):734-44.
2
Separation of plasminogen activators from human uterine tissue and a comparison with activators from human urine and porcine tissue.从人子宫组织中分离纤溶酶原激活剂,并与人尿和猪组织中的激活剂进行比较。
Thromb Haemost. 1979 Jun 30;41(4):718-33.
3
An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.对正常血浆以及缺乏因子XII和前激肽释放酶的血浆中硫酸葡聚糖优球蛋白组分中单链尿激酶型纤溶酶原激活剂(scu-PA)激活剂的分析。
Thromb Haemost. 1991 Feb 12;65(2):144-8.
4
Immunological characterization of plasminogen activator activities in human tissues and body fluids.人体组织和体液中纤溶酶原激活剂活性的免疫学特性
J Lab Clin Med. 1981 Apr;97(4):477-86.
5
The inhibition of tissue activator and urokinase by human plasma.人血浆对组织激活剂和尿激酶的抑制作用。
Thromb Haemost. 1982 Jun 28;47(3):265-8.
6
[Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].[从人胚肺成纤维细胞培养物中分离尿激酶型纤溶酶原激活剂及其特性]
Mol Biol (Mosk). 1986 May-Jun;20(3):778-88.
7
Plasminogen-activator in human early milk: its partial purification and characterization.人初乳中的纤溶酶原激活剂:其部分纯化及特性鉴定
Thromb Haemost. 1981 Apr 30;45(2):121-6.
8
Blood fibrinolytic system in rana tigrina.虎纹蛙的血液纤溶系统。
Thromb Haemost. 1981 Jun 30;45(3):252-4.
9
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
10
Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.赖氨酸纤溶酶原对单链或双链尿激酶型纤溶酶原激活剂或组织型纤溶酶原激活剂所致血凝块溶解的增强作用。
Thromb Haemost. 1989 Jun 30;61(3):502-6.

引用本文的文献

1
Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.由尿激酶或组织型纤溶酶原激活剂激活的血浆中纤溶酶原和纤溶酶抑制剂复合物分子形式的形成顺序。
Biochem J. 1984 Oct 1;223(1):179-87. doi: 10.1042/bj2230179.
2
Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.人组织型纤溶酶原激活剂与小鼠二氢叶酸还原酶序列在中国仓鼠卵巢细胞中的共扩增与共表达。
Mol Cell Biol. 1985 Jul;5(7):1750-9. doi: 10.1128/mcb.5.7.1750-1759.1985.